Parvin Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
5,739
+95
+2% +$33.9K 1.46% 12
2025
Q4
$1.85M Buy
5,644
+170
+3% +$53.9K 1.47% 12
2025
Q3
$1.54M Sell
5,474
-121
-2% -$35.1K 1.35% 13
2025
Q2
$1.56M Sell
5,595
-39
-0.7% -$11K 1.57% 10
2025
Q1
$1.76M Buy
5,634
+49
+0.9% +$14.5K 1.92% 8
2024
Q4
$1.46M Buy
+5,585
New +$1.66M 1.54% 12

Other funds holding AMGN

Parvin Asset Management's AMGN Position: Q1 2026 in Review

Parvin Asset Management increased its Amgen (AMGN) stake by 1.7% in Q1 2026, buying an estimated $33.9K and bringing the position to 5,739 shares worth $2.02M. The position accounts for 1.46% of the portfolio, ranked #12.

Parvin Asset Management first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Parvin Asset Management held 5,739 shares of Amgen worth $2.02M as of Q1 2026.
  • Parvin Asset Management bought 95 Amgen shares in Q1 2026, an estimated $33.9K.
  • Amgen made up 1.46% of Parvin Asset Management's portfolio in Q1 2026, its #12 holding.
  • Parvin Asset Management first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Parvin Asset Management's 13F filing for Q1 2026, filed 18 May 2026.